About Rote Liste®
For more than 90 years, Rote Liste has been the trusted, neutral, and advertising-free source of medicinal product information in Germany.
Our mission is to provide high-quality, comprehensive, and up-to-date information on medicinal products for healthcare professionals and patients, ensuring that it is easily accessible, unbiased, and barrier-free.
We understand the needs of our customers and users and offer tailored solutions for the publication, maintenance, and distribution of medicinal product information. As an established partner of the pharmaceutical industry, we actively contribute to making essential information available to physicians, pharmacists, and patients at the right time and in the right format.
Our daily work is guided by a clear set of principles:
Neutrality & Timeliness
Reliability & Quality
Transparency
Commitment to Healthcare
Our History: From Printed Publications to Digital Medicines Information

The origins of Rote Liste date back to 1933. Early on, the pharmaceutical industry recognized the importance of reliable medicinal product information and began making it available in a structured way. For decades, the annual print edition served as the leading reference work for healthcare professionals across Germany.
Key Milestones in Our History:
1933
Publication of the first edition as a pricing directory of German pharmaceutical specialty products, later known as Rote Liste®.
1990
Introduction of electronic data media.
1998
Launch of online publication services.
2021
Rote Liste Service GmbH becomes part of the Bertelsmann Group.
2026
Rote Liste and medicines.ie, Ireland’s medicines information directory, are among the co-founders of the Alliance for Medicines Information (AMI).
The Management Team

Working Together for a Healthier Future
As a team, we work collaboratively, trustfully, and with a strong sense of personal responsibility, united by a clear goal: to make medicinal product information as useful and accessible as possible. For our customers. For healthcare professionals. For patients. And for a safe and well-informed healthcare system.
Rote Liste Commission: Advancing Development Together with the Industry
The Rote Liste (RL) Commission is a permanent advisory body composed of Rote Liste employees as well as representatives from the pharmaceutical industry.
One of the Commission's key responsibilities is to provide recommendations on the overall structure and development of Rote Liste and to define formal requirements for the inclusion of medicinal products. In addition, the RL Commission supports ongoing projects and contributes practical industry expertise and experience. This close collaboration creates a strong link between editorial excellence, regulatory requirements, and the day-to-day realities of pharmaceutical companies, ensuring that Rote Liste continues to meet the evolving needs of the healthcare sector.
One of the Commission's key responsibilities is to provide recommendations on the overall structure and development of Rote Liste and to define formal requirements for the inclusion of medicinal products. In addition, the RL Commission supports ongoing projects and contributes practical industry expertise and experience. This close collaboration creates a strong link between editorial excellence, regulatory requirements, and the day-to-day realities of pharmaceutical companies, ensuring that Rote Liste continues to meet the evolving needs of the healthcare sector.
Newsletter
Stay informed
Subscribe to our newsletter for pharmaceutical companies to receive regular updates from Rote Liste.



